CS Wong, I Wahedna, ID Pavord and AE Tattersfield
Respiratory Medicine Unit, City Hospital, Nottingham, United Kingdom.

There is a transient rebound increase in bronchial reactivity to histamine and methacholine following regular treatment with an inhaled beta 2-agonist. We set out to determine whether the response to allergen was increased after cessation of regular inhaled terbutaline and whether concomitant inhaled budesonide modifies this response. In a double-blind, double-dummy, parallel group design we studied 41 subjects (37 evaluable) with mild asthma who were allergic to Dermatophagoides pteronyssinus, grass pollen, or cat fur. Following a 2 wk run-in period, subjects underwent a fixed three-dose allergen challenge based on their previously determined provocative concentration of allergen producing a 20% fall in FEV1 (PC20) before starting terbutaline 1,000 micrograms or placebo three times daily and budesonide 800 micrograms or placebo twice daily for a period of 2 to 4 wk (mean 18 d). The same three-dose allergen challenge was repeated 33 h after stopping treatment. During treatment evening peak flow values were highest in the terbutaline plus budesonide group. Following regular terbutaline there was no rebound increase in bronchial reactivity to allergen. Following budesonide there was a significantly smaller response to allergen and an increased FEV1 compared with the other three groups, including the budesonide plus terbutaline group. The changes in median (95% CI) allergen PC20 after budesonide, terbutaline, budesonide plus terbutaline, and placebo were 0.79 (0.3, 2.3), 0.11 (-0.4, 0.6), 0.24 (-0.4, 0.5) and -0.47 (-1.5, 0.1) doubling doses (p < 0.01). The respective changes in mean FEV1 were 0.34, -0.16, -0.01, and 0.06 L (p < 0.005). Thus bronchial reactivity to allergen was not increased after regular inhaled terbutaline.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				W. J. CALHOUN, K. L. HINTON, and J. J. KRATZENBERG The Effect of Salmeterol on Markers of Airway Inflammation Following Segmental Allergen Challenge Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 881 - 886. [Abstract] [Full Text]

				R. Jokic, V. A. Swystun, B. E. Davis, and D. W. Cockcroft Regular Inhaled Salbutamol : Effect on Airway Responsiveness to Methacholine and Adenosine 5'-Monophosphate and Tolerance to Bronchoprotection Chest, February 1, 2001; 119(2): 370 - 375. [Abstract] [Full Text] [PDF]

				R. E. ALDRIDGE, R. J. HANCOX, D. ROBIN TAYLOR, J. O. COWAN, M. C. WINN, C. M. FRAMPTON, and G. IAN TOWN Effects of Terbutaline and Budesonide on Sputum Cells and Bronchial Hyperresponsiveness In Asthma Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1459 - 1464. [Abstract] [Full Text]

				{beta}2-Agonists Can. Med. Assoc. J., November 1, 1999; 161(90111): s28 - 31. [Full Text]

				R J Hancox, J O Cowan, E M Flannery, G P Herbison, C R McLachlan, C S Wong, and D R Taylor Randomised trial of an inhaled beta 2 agonist, inhaled corticosteroid and their combination in the treatment of asthma Thorax, June 1, 1999; 54(6): 482 - 487. [Abstract] [Full Text]

				R. J Hancox, D. A Stevens, I. M Adcock, P. J Barnes, and D R. Taylor Effects of inhaled beta  agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma Thorax, June 1, 1999; 54(6): 488 - 492. [Abstract] [Full Text]

				T W Harrison, J Oborne, P J Wilding, and A E Tattersfield Randomised placebo controlled trial of beta  agonist dose reduction in asthma Thorax, February 1, 1999; 54(2): 98 - 102. [Abstract] [Full Text]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				P. M. SELDON, D. A. STEVENS, I. M. ADCOCK, B. J. O'CONNOR, P. J. BARNES, and M. A. GIEMBYCZ Albuterol Does Not Antagonize the Inhibitory Effect of Dexamethasone on Monocyte Cytokine Release Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 803 - 809. [Abstract] [Full Text] [PDF]

				P. A. Eggleston Are beta -Adrenergic Bronchodilators Safe? Pediatrics, May 1, 1997; 99(5): 729 - 729. [Full Text]